Bone-sparing chemoradiotherapy for anal cancer - Results of a phase II trial by the Danish Anal Cancer Group - The DACG II (NCT05385250).
- DOI
- 10.1016/j.radonc.2026.111605
- Published
- 2026 Aug
- Container
- Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.radonc.2026.111605,
title = {Bone-sparing chemoradiotherapy for anal cancer - Results of a phase II trial by the Danish Anal Cancer Group - The DACG II (NCT05385250).},
author = {Spindler KG and Jakobsen AV and Pedersen EM and Lutz CM and Nyvang L and Hansen J and Ramlov A and Hvid CA and Serup-Hansen E and Wilken EE and Havelund BM and Kronborg CJS},
year = {2026},
journal = {Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology},
doi = {10.1016/j.radonc.2026.111605},
url = {https://doi.org/10.1016/j.radonc.2026.111605}
}RIS
TY - JOUR TI - Bone-sparing chemoradiotherapy for anal cancer - Results of a phase II trial by the Danish Anal Cancer Group - The DACG II (NCT05385250). AU - Spindler KG AU - Jakobsen AV AU - Pedersen EM AU - Lutz CM AU - Nyvang L AU - Hansen J AU - Ramlov A AU - Hvid CA AU - Serup-Hansen E AU - Wilken EE AU - Havelund BM AU - Kronborg CJS PY - 2026 JO - Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology DO - 10.1016/j.radonc.2026.111605 UR - https://doi.org/10.1016/j.radonc.2026.111605 ER -
APA
KG, S., AV, J., EM, P., CM, L., L, N., J, H., A, R., CA, H., E, S., EE, W., BM, H., & CJS, K. (2026). Bone-sparing chemoradiotherapy for anal cancer - Results of a phase II trial by the Danish Anal Cancer Group - The DACG II (NCT05385250).. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. https://doi.org/10.1016/j.radonc.2026.111605
Source records
- pubmed · retrieved 2026-09-26T01:43:48.694Z